Abstract:Backgroud: (-)-Epigallocatechin-3-gallate (EGCG), the major component of green tea, is well documented to induce apoptosis and cell cycle arrest in cancer by targeting multiple signal transduction pathways. However, EGCG is extremely unstable in general culture conditions and rapidly degraded. So, to what extent EGCG or which degradation products of EGCG play a role in anti-tumor is still unknown. In this study, we evaluated the effect of different treatments of EGCG on HCT116 cells.Design: MTT assay was applied to evaluated the inhibitory effect of different treatments of EGCG on HCT116 cells. Cell cycle and apoptosis were performed by flow cytometry. Finally, western blot analysis was used to elucidate the molecular mechanism associated with cell cycle arrest and apoptosis.Results: Compared with control, both EGCG and O-EGCG (i.e., EGCG being pre-incubated at 37 degrees C for 3 h) significantly inhibited HCT116 cells growth. Surprisingly, we found that the inhibitory effect of O-EGCG was stronger than that of EGCG. The IC50 values of EGCG and O-EGCG were 8.75 and 5.40 M, respectively. Cell cycle analysis showed that 20 M of EGCG simultaneously caused cell cycle arrest at G1 and G2 phase in HCT116 cells, differing from O-EGCG which exclusively caused cell cycle arrest at G2. This result suggested that parent EGCG at the early treatment might cause cell cycle arrest at G1. As time went on, EGCG disappeared and degraded products of EGCG were formed which might cause cell cycle arrest at G2. Further studies revealed that EGCG induced cell cycle arrest at G1 by downregulation of cyclin E and cyclin D1 and upregulation of p21. On the other hand, O-EGCG induced HCT116 cells apoptosis mainly by increasing the expression of p53 and cleaved caspase-3, which might be the underlying reason why O-EGCG had stronger inhibitory effect on HCT116 cells line than EGCG.Conclusions: The pretreatment of EGCG may be an effective way to enhance its antitumor effect.

Cytotoxicity of Epigallocatechin-3-gallate to LNCaP Cells in the Presence of Cu 2+

Growth inhibition of prostate cancer cells by epigallocatechin gallate in the presence of Cu2+.

Effects of Epi-Gallocatechin Gallate on PC-3 Cell Cytoplasmic Membrane in the Presence of Cu2+

Growth Inhibition of Prostate Cancer Cells by Epigallocatechin Gallate in the Presence of Cu<sup>2+</sup>

Inhibitory Effects of Epigallocatechin Gallate (EGCG) and Cd2+ on the Growth of Prostate Cancer PC-3 Cell

Growth Inhibition Of Prostate Cancer Cells By Epigallocatechin Gallate In The Presenceof Cu2+

Effects of interactions of EGCG and Cd2+ on the growth of PC-3 cells and their mechanisms

Effect of Interactions Between EGCG and Zn2+ on the Growth of Prostate Cancer PC-3 Cells

Role of Zn2+ in epigallocatechin gallate affecting the growth of PC-3 cells.

Effect of Interactions Between EGCG and Zn~(2+) on Energy Metabolism of PC-3 Cells

Investigations of the Cytotoxicity of Epigallocatechin-3-gallate Against PC-3 Cells in the Presence of Cd2+in Vitro

Epigallocatechin-3-gallate affects the growth of LNCaP cells via membrane fluidity and distribution of cellular zinc

[Growth Inhibition of Prostate Cancer Cells by Epigallocatechin-3-gallate in the Presence of Zn2+ in Vitro].

Lipophilized Epigallocatechin Gallate Derivative Exerts Anti-Proliferation Efficacy Through Induction of Cell Cycle Arrest and Apoptosis on DU145 Human Prostate Cancer Cells

Epigallocatechin Gallate-Β-lactoglobulin Nanoparticles Improve the Antitumor Activity of EGCG for Inducing Cancer Cell Apoptosis

Mechanism of Free Zn(2+) Enhancing Inhibitory Effects of EGCG on the Growth of PC-3 Cells: Interactions with Mitochondria

(-)-Epigallocatechin-3-gallate Induces Non-Apoptotic Cell Death in Human Cancer Cells Via Ros-Mediated Lysosomal Membrane Permeabilization

The Effect of Different Treatments of (-)-Epigallocatechin-3-Gallate on Colorectal Carcinoma Cell Lines.

Egcg Inhibits Cd2+-Induced Apoptosis Through Scavenging Ros Rather Than Chelating Cd2+ in Hl-7702 Cells

Anti-metastatic and Differential Effects on Protein Expression of Epigallocatechin-3-gallate in HCCLM6 Hepatocellular Carcinoma Cells

(−)‐Epigallocatechin‐3‐gallate Induces Du145 Prostate Cancer Cell Death Via Downregulation of Inhibitor of DNA Binding 2, a Dominant Negative Helix‐loop‐helix Protein